Drug-Eluting Stent Restenosis
The Pattern Predicts the Outcome
John Cosgrave, MRCP*,
Gloria Melzi, MD*,
Giuseppe G.L. Biondi-Zoccai, MD
,
Flavio Airoldi, MD
,
Alaide Chieffo, MD
,
Giuseppe M. Sangiorgi, MD*,
Matteo Montorfano, MD
,
Iassen Michev, MD
,
Mauro Carlino, MD
,
Erminio Bonizzoni, PhD
and
Antonio Colombo, MD, FACC*,
,*
* EMO Centro Cuore Columbus, Milan, Italy
San Donato Hospital, Milan, Italy
San Raffaele Hospital, Milan, Italy
Institute of Medical Statistics and Biometry, University of Milan, Milan, Italy.

View larger version (17K):
[in a new window]
|
Figure 1 Clinical status and results of noninvasive functional tests in patients with and without angiographic follow-up. EST = stress EKG or myocardial scintigraphy or stress echocardiogram.
|
|

View larger version (34K):
[in a new window]
|
Figure 2 Pattern of restenosis at baseline and follow-up of the lesions treated which restenosed for the second time.
|
|

View larger version (22K):
[in a new window]
|
Figure 3 Clinical status and results of noninvasive functional tests in patients with and without target lesion revascularization (TLR). CX = circumflex; EST = stress EKG or myocardial scintigraphy or stress echocardiogram; ISR = in-stent restenosis; IVUS = intravascular ultrasound; LAD = left anterior descending; QCA = quantitative coronary angiography; RCA = right coronary artery.
|
|
Copyright © 2006 by the American College of Cardiology Foundation.